Lignocaine + Adrenaline injection
Therapeutic agent (verify pharmacological class)
What it is used for
Local anesthesia [in adults and children above 12 yrs]. See under the "Dosage" below for details. Clinical selection for Lignocaine + Adrenaline injection should follow culture results where relevant, Kenya STG/EML recommendations, and the current product SmPC. Class context: Therapeutic agent (verify pharmacological class). Confirm site-specific dose, duration and monitoring before prescribing.
Warnings
Obtain allergy and medication history. Adjust for renal/hepatic impairment, pregnancy, lactation, extremes of age and interacting drugs. Use the lowest effective dose for the shortest appropriate duration. Monitor for expected class adverse effects.
Possible side effects
Acute toxic reactions in case of accidental intravascular injection. Drowsiness; dizziness; disorientation; confusion; lightheadedness; psychosis; apprehension; tinnitus; visual disturbances including amblyopia or diplopia; nausea; vomiting; paraesthesia; sensations of heat, cold, or numbness; difficulty swallowing; dyspnea; and slurred speech; muscle twitching or tremors, seizures, unconsciousness, coma, and respiratory depression; hypersensitivity reaction; hypotension, arrhythmias, heart block; local thrombophlebitis.
Storage
Store as labelled. Keep out of reach of children.
No reviewed patient-education article is available. The fields shown are from the currently verified medicine record and unavailable fields are not inferred.